ImaginAb Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ImaginAb Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10321
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ImaginAb Inc (ImaginAb) is an immune and oncology imaging company that develops in vivo antibody-based imaging agents. It is engaged in the discovery, development, and production of new compounds and products in human health and cosmetics, agriculture and food sectors. The company’s product portfolio includes fungicides, herbicides, and insecticides among others. Biomar’s pharmaceutical preclinical pipeline comprises compounds for cancer, glioblastoma, and infectious and autoimmune diseases. The company also offers services such as taxonomical identification, screening and active compound identification. The company is funded by Cycad Group, Raptor, and Nextech Invest Ltd among others. It has operation in the US and Japan. ImaginAb is headquartered in Inglewood, California, the US.

ImaginAb Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ImaginAb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ImaginAb Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ImaginAb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ImaginAb Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ImaginAb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ImaginAb Inc, Medical Equipment, Deal Details 10
Venture Financing 10
ImaginAb Raises USD7.7 Million in Venture Financing 10
ImaginAb Raises USD5.3 Million in Financing 11
ImaginAb Raises USD21 Million in Series B Venture Financing 12
ImaginAb Raises US$12.5 Million In Series A Financing 13
Partnerships 14
Merck Enters into Licensing Agreement with ImaginAb 14
ImaginAb Enters into Technology Licensing Agreement with University of California, Los Angeles 15
ImaginAb Exercises Option For Licensing Agreement With Oxford BioMedica To License Vivo 5T4-Based Imaging Diagnostic 16
ImaginAb Extends Licensing Agreement With Bzl Biologics For Imaging Prostate Specific Membrane Antigen 17
ImaginAb Enters into Agreement with Boehringer Ingelheim 18
ImaginAb Enters Into Co-Development Agreement With MacroGenics 19
ImaginAb Inc – Key Competitors 20
ImaginAb Inc – Key Employees 21
ImaginAb Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Corporate Communications 23
Jul 09, 2018: ImaginAb Appoints James Allison, Padmanee Sharma and Ramy Ibrahim to Scientific Advisory Board 23
Jun 22, 2018: Imagin Reconstitutes Japanese Subsidiary 24
May 17, 2018: ImaginAb Reconstitutes Scientific Advisory Board 25
Feb 06, 2018: ImaginAb Names Ian Wilson As Chief Operating Officer 26
Mar 22, 2017: ImaginAb Appoints Martyn Coombs as New Chief Executive Officer 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
ImaginAb Inc, Medical Equipment, Key Facts 2
ImaginAb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ImaginAb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ImaginAb Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ImaginAb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ImaginAb Inc, Deals By Market, 2012 to YTD 2018 8
ImaginAb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ImaginAb Raises USD7.7 Million in Venture Financing 10
ImaginAb Raises USD5.3 Million in Financing 11
ImaginAb Raises USD21 Million in Series B Venture Financing 12
ImaginAb Raises US$12.5 Million In Series A Financing 13
Merck Enters into Licensing Agreement with ImaginAb 14
ImaginAb Enters into Technology Licensing Agreement with University of California, Los Angeles 15
ImaginAb Exercises Option For Licensing Agreement With Oxford BioMedica To License Vivo 5T4-Based Imaging Diagnostic 16
ImaginAb Extends Licensing Agreement With Bzl Biologics For Imaging Prostate Specific Membrane Antigen 17
ImaginAb Enters into Agreement with Boehringer Ingelheim 18
ImaginAb Enters Into Co-Development Agreement With MacroGenics 19
ImaginAb Inc, Key Competitors 20
ImaginAb Inc, Key Employees 21

List of Figures
ImaginAb Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ImaginAb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ImaginAb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ImaginAb Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ImaginAb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ImaginAb Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ImaginAb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ImaginAb Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ImaginAb Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupo Televisa, S.A.B. (TLEVISACPO):企業の財務・戦略的SWOT分析
    Grupo Televisa, S.A.B. (TLEVISACPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • AM Conservation Group Inc:電力:M&Aディール及び事業提携情報
    Summary AM Conservation Group Inc (AM Conservation) a subsidiary of Kohlberg & Company LLC is a clean technology company that manufactures, designs and distributes energy conservation products. The company provides products such as water conservation products, energy efficient products, energy effic …
  • A. O. Smith Corporation:企業の戦略・SWOT・財務情報
    A. O. Smith Corporation - Strategy, SWOT and Corporate Finance Report Summary A. O. Smith Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Enerplus Corp (ERF):石油・ガス:M&Aディール及び事業提携情報
    Summary Enerplus Corp (Enerplus), formerly Enerplus Resources Fund is an oil and gas company that offers exploration and development services. The company provides exploration and development of natural resource properties for the production of crude oil, light and heavy oil, natural gas, shallow ga …
  • Heidelberg Pharma AG (WL6):製薬・医療:M&Aディール及び事業提携情報
    Summary Heidelberg Pharma AG (Heidelberg Pharma) formerly, Wilex AG is a biopharmaceutical company. The company develops therapeutic and diagnostic product candidates for the treatment and specific detection of various cancers. Heidelberg Pharma’s pipeline products are focused on treating multiple m …
  • Archrock Partners LP:企業のM&A・事業提携・投資動向
    Archrock Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Archrock Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • E.ON UK Plc:企業の発電所・SWOT分析2018
    E.ON UK Plc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Kallpa Generacion SA:発電所・企業SWOT分析
    Kallpa Generacion SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Sally Beauty Holdings, Inc.:企業の戦略・SWOT・財務情報
    Sally Beauty Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sally Beauty Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • University of Cape Town-製薬・医療分野:企業M&A・提携分析
    Summary University of Cape Town (UCT) is a public research university that offers educational services. The university offers services for faculty of commerce, faculty of engineering and the built environment, faculty of health sciences, faculty of humanities, faculty of law and faculty of science. …
  • Alsea SAB de CV:企業の戦略・SWOT・財務情報
    Alsea SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Alsea SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Serco Group plc (SRP):企業の財務・戦略的SWOT分析
    Serco Group plc (SRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Orsted AS:企業の発電所・SWOT分析2018
    Orsted AS - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • Avalign Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Avalign Technologies Inc (Avalign), a subsidiary of Arlington Capital Partners, is a medical device company that supplies surgical implants, instruments, and delivery systems. The company offers precision machined instruments, cutting instruments, delivery systems, cases and trays, german sp …
  • Molecular Partners AG (MOLN):企業の財務・戦略的SWOT分析
    Summary Molecular Partners AG (Molecular Partners) is a clinical stage biopharmaceutical company that develops biological drugs. The company offers advanced small protein therapies such as abicipar, a designed ankyrin repeat protein based anti-angiogenic drug developed for diabetic macular edema and …
  • Ingles Markets Inc:企業の戦略・SWOT・財務分析
    Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report Summary Ingles Markets Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hsh Nordbank Private Banking:企業の戦略・SWOT・財務分析
    Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report Summary Hsh Nordbank Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • GFT Technologies AG (GFT):企業の財務・戦略的SWOT分析
    Summary GFT Technologies AG (GFT Technologies) is a technology company that implements, develops, and maintains information technology solutions. The company’s services comprise application management, bespoke development, product based implementation, and business and IT consultation services. It a …
  • EBN B.V.:石油・ガス:M&Aディール及び事業提携情報
    Summary EBN BV (EBN) is an independent oil and natural gas company that carries out exploration, production, storage and trading of oil and natural gas. The company participates in nearly all the exploration and production activities in the Netherlands through a public-private partnership model. It …
  • Aisin Seiki Co Ltd (7259):企業の財務・戦略的SWOT分析
    Aisin Seiki Co Ltd (7259) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆